P3 Health Partners Inc. (PIII): Cash & Equivalents
$25.01M
As of 2025-12-31
$21.27M
As of 2026-06-30
+12.6%
3-year compound annual growth
-7.2%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.01M | -35.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $38.82M | +6.9% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $36.32M | +107.1% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $17.54M | -87.5% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $140.48M | n/a | 2023-03-31, Balance as of period end |
| 2021-12-02 | $5.30M | n/a | 2023-03-31, Balance as of period end |
| 2020-12-31 | $36.26M | +11.3% | 2022-10-21, Balance as of period end |
| 2019-12-31 | $32.59M | n/a | 2022-10-21, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| P3 Health Partners Inc. (PIII) | 2025-12-31 | $25.01M | -35.6% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $248.64M | +60.9% |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $479.69M | -2.3% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $97.89M | +52.6% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $35.57M | -14.0% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $105.00M | +23.2% |
| DocGo Inc. (DCGO) | 2025-12-31 | $51.02M | -42.8% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $222.04M | +190.7% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $30.97M | +68.5% |
Compare PIII, LFST, PRVA, INNV side by side · Screen every company in Services-Health Services ↗